Commentary - (2015) Volume 4, Issue 3
Blinatumomab: A Promising New Drug in the Therapeutic Armamentarium for
Acute Lymphoblastic Leukemia
- Josep-Maria Ribera*
- Department of Clinical Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Universitat Autònoma de Barcelona, Spain
*Corresponding Author:
Josep-Maria Ribera, Department Clinical Hematology ICO-Hospital Germans, Trias i Pujol Jose Carreras Research Institutec/CanyetS/N08916, Badalona, Spain, Tel: 34 93 4978987, Fax: 34 93 4978995
Email:
